The Skin Microbiome and its Significance for Dermatologists Cleo WhitingSara Abdel AzimAdam Friedman Leading Article 22 January 2024 Pages: 169 - 177
Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors Richard W. KimMegan LamAaron M. Drucker Review Article 12 January 2024 Pages: 179 - 193
Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update Meropi KarakioulakiKilian EyerichAikaterini Patsatsi Review Article Open access 29 December 2023 Pages: 195 - 212
Recent Advances in Treatment of Systemic Sclerosis and Morphea Noelle TeskeNicole Fett Review Article 12 December 2023 Pages: 213 - 226
Rare Autoinflammatory Neutrophilic Dermatoses in Pregnancy: Literature Review Angela LoBrittany ThompsonNaveed Sami Review Article 13 December 2023 Pages: 227 - 242
Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options Tejas P. JoshiMadeleine Duvic Review Article 30 December 2023 Pages: 243 - 259
Pressure and Skin: A Review of Disease Entities Driven or Influenced by Mechanical Pressure Wei-Chen ChienTsen-Fang Tsai Review Article 30 December 2023 Pages: 261 - 280
Mucocutaneous Manifestations of Recreational Drug Use Carolina V. Alexander-SavinoGinat W. MirowskiDonna A. Culton Review Article 13 January 2024 Pages: 281 - 297
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program Brett KingJennifer SoungAlexandre Lejeune Original Research Article Open access 23 January 2024 Pages: 299 - 314
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial Luis PuigAntonio CostanzoCurdin Conrad Original Research Article Open access 07 October 2023 Pages: 315 - 325
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year Wilson HuMichele ThorntonRobert A. Livingston Original Research Article Open access 19 January 2024 Pages: 327 - 332
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study Tiago TorresAndrea ChiricozziPaolo Gisondi Original Research Article Open access 24 January 2024 Pages: 333 - 342
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program Jill T. ShahWilliam Mark RichardsonAlisa N. Femia Research Letter 02 February 2024 Pages: 343 - 345